SCHEMBL311129

SCHEMBL311129

CCOC(=O)Nc1cc(O)c(O)cc1-c1cc(=O)c2ccccc2o1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.63
KDM4E B2RXH2 6/20 0.63
HSD17B10 Q99714 3/20 0.63
LMNA P02545 1/20 0.63
TNKS O95271 3/20 0.54
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
AKR1C1 Q04828 1/20 0.52
MAOB P27338 1/20 0.51
CYP3A4 P08684 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
CYP2C9 P11712 3/20 0.50
CYP2C19 P33261 3/20 0.50
CSNK2A2 P19784 2/20 0.50
CSNK2B P67870 2/20 0.50
CSNK2A1 P68400 2/20 0.50
MAPT P10636 4/20 0.49
ALOX15 P16050 2/20 0.49
CYP2D6 P10635 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL324201 0.88 HPGD (0.61) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL312009 0.85 KDM4E (0.58) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL311628 0.85 HPGD (0.45) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL311578 0.85 HPGD (0.45) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL312706 0.84 KDM4E (0.61) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL311138 0.83 HPGD (0.58) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL312665 0.83 MAOB (0.45) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL312404 0.83 HPGD (0.45) HPGDKDM4EHSD17B10LMNATNKS
SCHEMBL311430 0.82 KDM4E (0.53) HPGDKDM4EHSD17B10LMNAMAOB
SCHEMBL311720 0.80 HPGD (0.59) HPGDKDM4EHSD17B10LMNATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed